Plasmatech Biopharmaceuticals Inc Stock Nasdaq
Equities
US72754H1095
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
May. 03 | Abeona Therapeutics Prices $75 Million Securities Offering; Shares Rise | MT |
Apr. 23 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Financials (USD)
Sales 2024 * | 500K | Sales 2025 * | 22.83M | Capitalization | 126M |
---|---|---|---|---|---|
Net income 2024 * | -60M | Net income 2025 * | -63M | EV / Sales 2024 * | 252 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.51 x |
P/E ratio 2024 * |
-2.15
x | P/E ratio 2025 * |
-2.43
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.79% |
Latest transcript on Plasmatech Biopharmaceuticals Inc
Managers | Title | Age | Since |
---|---|---|---|
Vishwas Seshadri
CEO | Chief Executive Officer | 48 | 21-05-31 |
Michael Amoroso
CHM | Chairman | 46 | 20-07-08 |
Joseph Vazzano
DFI | Director of Finance/CFO | 40 | 22-03-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Alvino
BRD | Director/Board Member | 56 | 06-02-28 |
Faith Charles
BRD | Director/Board Member | 62 | 21-03-24 |
Leila Alland
BRD | Director/Board Member | 61 | 21-04-18 |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |